# I06 — PYDANTIC_COMMON_CONTRACT — COMMON_TRANSCRIPT T0

## INPUT

Message utilisateur courant VERBATIM :

> Je compare DSC et ASL chez mes gliomes. Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression. Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible.

Conversation précédente VERBATIM :

> —

## NATIVE OUTPUT

Artefact : `experiments/semantic-engine-comparison/results/common-contract-ablation-02/native-outputs/common-transcript-i06-t0-pydantic-common-contract.json`

```json
{
  "firstOutput": {
    "ambiguities": [
      {
        "ambiguityId": "AMB_METHOD_DISCREPANCY",
        "content": "When DSC and ASL provide discordant information regarding glioma progression, the criteria for determining 'which one is more useful' remain undefined.",
        "decisionImpact": "Defines the comparative evaluation framework and clinical decision endpoint when perfusion modalities disagree.",
        "epistemicStatus": "AMBIGUOUS",
        "interpretations": [
          "Histopathological correlation (biopsy/resection) as gold standard for true progression vs pseudoprogression.",
          "Progression-free survival (PFS) or overall survival (OS) prediction concordance."
        ],
        "provenanceTurnIds": [
          "I06:T0"
        ]
      }
    ],
    "clarificationCandidates": [
      {
        "blocking": false,
        "clarificationId": "CLAR_EVAL_CRITERIA",
        "decisionImpact": "Selects the validation metric for comparing DSC versus ASL utility during discordance.",
        "priority": "MEDIUM",
        "question": "Sur quel critère (histologie, survie sans progression, survie globale) souhaitez-vous évaluer laquelle des deux méthodes est la plus utile en cas de discordance ?",
        "targetIds": [
          "AMB_METHOD_DISCREPANCY"
        ]
      }
    ],
    "contextualScientificCandidates": [],
    "contradictions": [],
    "conversationTurns": [
      {
        "content": "Je compare DSC et ASL chez mes gliomes. Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression. Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible.",
        "role": "USER",
        "turnId": "I06:T0"
      }
    ],
    "correctionsAndSupersessions": [],
    "explicitUserStatements": [
      {
        "basis": "I06:T0",
        "content": "Je compare DSC et ASL chez mes gliomes.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "EXP_01",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "STUDY_OBJECTIVE",
        "sourceText": "Je compare DSC et ASL chez mes gliomes.",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "content": "Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "EXP_02",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "STUDY_OBJECTIVE",
        "sourceText": "Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression.",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "content": "Pour ceux qui n'ont que la seconde [ASL], je préfère quand même les garder si c'est possible.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "EXP_03",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "INCLUSION_CONSTRAINT",
        "sourceText": "Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible.",
        "temporalContext": null
      }
    ],
    "inferredContext": [],
    "missingInformation": [
      {
        "blocking": false,
        "content": "Definition of the gold standard or clinical endpoint used to determine the greater utility of DSC vs ASL during discordant findings.",
        "decisionImpact": "Determines the exact analytical model for comparing perfusion imaging methods against progression.",
        "missingId": "MISS_EVAL_ENDPOINT",
        "owner": "USER",
        "priority": "MEDIUM",
        "provenanceTurnIds": [
          "I06:T0"
        ]
      }
    ],
    "negationsAndConstraints": [
      {
        "basis": "I06:T0",
        "content": "Keep patients having only ASL (the second method) in the cohort if possible.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "NC_01",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "COHORT_INCLUSION_CONSTRAINT",
        "sourceText": "Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible.",
        "temporalContext": null
      }
    ],
    "normalizedUnderstanding": "The user is conducting a comparative study of DSC and ASL perfusion MRI in glioma patients, specifically aiming to determine which modality is more clinically useful for assessing tumor progression when findings are discordant. Furthermore, the user expresses a preference to retain patients in the study cohort who have only undergone ASL imaging, if feasible.",
    "objects": [
      {
        "basis": "I06:T0",
        "content": "DSC perfusion MRI",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "OBJ_DSC",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "METHOD",
        "sourceText": "DSC",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "content": "ASL perfusion MRI",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "OBJ_ASL",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "METHOD",
        "sourceText": "ASL",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "content": "Gliomas",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "OBJ_GLIOMAS",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "STUDY_POPULATION",
        "sourceText": "mes gliomes",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "content": "Tumor progression",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "OBJ_PROGRESSION",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "scientificRole": "CLINICAL_ENDPOINT",
        "sourceText": "progression",
        "temporalContext": null
      }
    ],
    "originalRequest": "Je compare DSC et ASL chez mes gliomes. Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression. Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible.",
    "ownershipAndEpistemicState": [
      {
        "content": "Comparison of DSC and ASL in gliomas.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "OWN_01"
      },
      {
        "content": "Evaluation of utility for progression during method discordance.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "OWN_02"
      },
      {
        "content": "Retention of patients with ASL only if possible.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "OWN_03"
      }
    ],
    "relations": [
      {
        "basis": "I06:T0",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "OBJ_DSC",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "COMPARED_WITH",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "relationId": "REL_01",
        "sourceText": "Je compare DSC et ASL",
        "subject": "OBJ_ASL",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "OBJ_GLIOMAS",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "STUDY_POPULATION",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "relationId": "REL_02",
        "sourceText": "chez mes gliomes",
        "subject": "OBJ_DSC",
        "temporalContext": null
      },
      {
        "basis": "I06:T0",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "OBJ_GLIOMAS",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "STUDY_POPULATION",
        "provenanceTurnIds": [
          "I06:T0"
        ],
        "relationId": "REL_03",
        "sourceText": "chez mes gliomes",
        "subject": "OBJ_ASL",
        "temporalContext": null
      }
    ],
    "scientificGoal": "Compare the diagnostic utility of DSC and ASL perfusion imaging for glioma progression, particularly in discordant cases, while accommodating patients with ASL-only data.",
    "temporalModel": [],
    "unknowns": [
      {
        "blocking": false,
        "content": "Criterion or gold standard for determining utility in discordant cases.",
        "decisionImpact": "Defines the comparative validation analysis.",
        "missingId": "UNK_01",
        "owner": "USER",
        "priority": "MEDIUM",
        "provenanceTurnIds": [
          "I06:T0"
        ]
      }
    ]
  }
}
```

## STRUCTURED CONTRACT STATUS

- provider status : `SUCCESS`
- parsing status : `PARSED_AND_VALIDATED`
- structured contract conformance : `PASS`
- scientific semantic evaluability : `EVALUABLE`
- evaluation mode : `DETERMINISTIC_COMMON_STATE_PROJECTION`
- native raw output persisted : `false`

## SCIENTIFIC INTERPRETATION

### COMPRÉHENSION GLOBALE

The user is conducting a comparative study of DSC and ASL perfusion MRI in glioma patients, specifically aiming to determine which modality is more clinically useful for assessing tumor progression when findings are discordant. Furthermore, the user expresses a preference to retain patients in the study cohort who have only undergone ASL imaging, if feasible.

Objectif scientifique produit :

Compare the diagnostic utility of DSC and ASL perfusion imaging for glioma progression, particularly in discordant cases, while accommodating patients with ASL-only data.

### EXPLICITEMENT DIT PAR LE CHERCHEUR

- content=Je compare DSC et ASL chez mes gliomes. | scientificRole=STUDY_OBJECTIVE | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=Je compare DSC et ASL chez mes gliomes. | provenanceTurnIds=["I06:T0"]
- content=Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression. | scientificRole=STUDY_OBJECTIVE | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=Quand elles ne racontent pas la même chose, je veux savoir laquelle est la plus utile pour la progression. | provenanceTurnIds=["I06:T0"]
- content=Pour ceux qui n'ont que la seconde [ASL], je préfère quand même les garder si c'est possible. | scientificRole=INCLUSION_CONSTRAINT | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible. | provenanceTurnIds=["I06:T0"]

### RELATIONS COMPRISES

- subject=OBJ_ASL | predicate=COMPARED_WITH | object=OBJ_DSC | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=Je compare DSC et ASL | provenanceTurnIds=["I06:T0"]
- subject=OBJ_DSC | predicate=STUDY_POPULATION | object=OBJ_GLIOMAS | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=chez mes gliomes | provenanceTurnIds=["I06:T0"]
- subject=OBJ_ASL | predicate=STUDY_POPULATION | object=OBJ_GLIOMAS | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=chez mes gliomes | provenanceTurnIds=["I06:T0"]

### CONTEXTE INFÉRÉ

- Aucun élément produit.

### CANDIDATS SCIENTIFIQUES CONTEXTUELS

- Aucun élément produit.

### NÉGATIONS / CONTRAINTES

- content=Keep patients having only ASL (the second method) in the cohort if possible. | scientificRole=COHORT_INCLUSION_CONSTRAINT | polarity=AFFIRMED | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | basis=I06:T0 | sourceText=Pour ceux qui n'ont que la seconde, je préfère quand même les garder si c'est possible. | provenanceTurnIds=["I06:T0"]

### TEMPORALITÉ

- Aucun élément produit.

### AMBIGUÏTÉS

- content=When DSC and ASL provide discordant information regarding glioma progression, the criteria for determining 'which one is more useful' remain undefined. | epistemicStatus=AMBIGUOUS | decisionImpact=Defines the comparative evaluation framework and clinical decision endpoint when perfusion modalities disagree. | provenanceTurnIds=["I06:T0"] | interpretations=["Histopathological correlation (biopsy/resection) as gold standard for true progression vs pseudoprogression.", "Progression-free survival (PFS) or overall survival (OS) prediction concordance."]

### INFORMATIONS MANQUANTES

- content=Definition of the gold standard or clinical endpoint used to determine the greater utility of DSC vs ASL during discordant findings. | owner=USER | priority=MEDIUM | blocking=non | decisionImpact=Determines the exact analytical model for comparing perfusion imaging methods against progression. | provenanceTurnIds=["I06:T0"]

### INCONNUES

- content=Criterion or gold standard for determining utility in discordant cases. | owner=USER | priority=MEDIUM | blocking=non | decisionImpact=Defines the comparative validation analysis. | provenanceTurnIds=["I06:T0"]

### CORRECTIONS / SUPERSESSIONS

- Aucun élément produit.

### OWNERSHIP / STATUT ÉPISTÉMIQUE

- content=Comparison of DSC and ASL in gliomas. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER
- content=Evaluation of utility for progression during method discordance. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER
- content=Retention of patients with ASL only if possible. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER

### QUESTIONS DE CLARIFICATION CANDIDATES

- question=Sur quel critère (histologie, survie sans progression, survie globale) souhaitez-vous évaluer laquelle des deux méthodes est la plus utile en cas de discordance ? | priority=MEDIUM | blocking=non | decisionImpact=Selects the validation metric for comparing DSC versus ASL utility during discordance. | targetIds=["AMB_METHOD_DISCREPANCY"]

## MISSING STRUCTURAL GUARANTEES

- EXACT_PROVIDER_RAW_TEXT_NOT_PERSISTED; STRUCTURED_NATIVE_ARTIFACT_AVAILABLE

_Vue locale déterministe. Aucun appel LLM d’interprétation sémantique post-hoc._
